Supreme Court Says No To 9 Patent Cases
The U.S. Supreme Court on Monday refused to wade into nine patent cases, turning down Biogen's efforts to block its billion-dollar multiple sclerosis drug Tecfidera from facing market competition and a...To view the full article, register now.
Already a subscriber? Click here to view full article